Loading...
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...
Na minha lista:
| Udgivet i: | J Urol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/ https://ncbi.nlm.nih.gov/pubmed/25524243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|